Zinc-L-carnosine vs Larazotide
Written by Aaron CuhaReviewed Sep 2026
The short answer
Two gut lining products that both went through a regulator, with different endings. Zinc-L-carnosine has been a prescription stomach medicine in Japan since 1994 and has a positive large final stage trial. Larazotide's large final stage trial missed its main goal.
- Zinc-L-carnosine people
- 0
- Zinc-L-carnosine nulls
- 0
- Larazotide people
- 526
- Larazotide nulls
- 1
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
1 completed trial, 0 people given it
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
2 completed trials, 526 people given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
Zinc-L-carnosineZinc-L-carnosine (polaprezinc), zinc and carnosine chelate
In a final-stage trial in women having radiotherapy for breast cancer, it prevented trouble swallowing. It is a mix of zinc and a small peptide, approved as a stomach drug in Japan and sold as a supplement in the US.
Column B
LarazotideLarazotide Acetate (AT-1001)
A gut barrier peptide for celiac disease that is still being tested. It reached a large final-stage study, but the company stopped that study and never published a result.
Side by side, on the facts we can check
| What we compare | Zinc-L-carnosine | Larazotide |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| FDA status | Not an FDA-approved drug. Sold as a dietary supplement in the United States. In Japan it is an approved prescription stomach medicine, sold there since 1994. | Investigational; a final-stage study missed its main goal |
| Half-life | Not meaningfully described as a chelate, because its intended action is local adhesion to mucosa and local zinc release rather than systemic exposure. | Short (acts locally in the gut) |
| Molecular weight | Roughly 289 Da for the zinc and L-carnosine complex. | ~732 Da |
| How it works | Zinc-L-carnosine is one zinc locked onto one L-carnosine. The pair sticks mainly to sore, inflamed or ulcerated gut lining. There it comes apart and releases zinc right on the spot, at a higher level than a zinc pill would reach. Zinc helps repair the lining, steadies cell walls and boosts antioxidant defence, by raising a protein called metallothionein. Carnosine is an antioxidant itself and grabs loose metals. In a dish and in animals, it speeds up the lining cells moving in to close a wound, and it raises protective heat shock proteins. Its actions are mostly local to the lining. That is why the evidence is about gut and lining injury, not effects around the body. | It blocks zonulin signaling. That tightens the seals between gut lining cells, called tight junctions, and keeps pieces of gluten from slipping through. |
| Studies in people | 1 | 3 |
| Evidence | Limited: 1 completed trial, none stating how many people | Moderate: 2 completed trials, 526 people given it |
| Legal status, US | Sold as a supplement | Investigational, not approved |
Frequently asked questions
What is the difference between Zinc-L-carnosine and Larazotide?
Zinc-L-carnosine: In a final-stage trial in women having radiotherapy for breast cancer, it prevented trouble swallowing. It is a mix of zinc and a small peptide, approved as a stomach drug in Japan and sold as a supplement in the US. Larazotide: A gut barrier peptide for celiac disease that is still being tested. It reached a large final-stage study, but the company stopped that study and never published a result.
Which has stronger research evidence, Zinc-L-carnosine or Larazotide?
Each compound gets a band worked out from facts we counted, with the math shown. Zinc-L-carnosine is Limited (1 completed trial, none stating how many people). Larazotide is Moderate (2 completed trials, 526 people given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Zinc-L-carnosine and Larazotide FDA-approved?
Zinc-L-carnosine: Not an FDA-approved drug. Sold as a dietary supplement in the United States. In Japan it is an approved prescription stomach medicine, sold there since 1994.. Larazotide: Investigational; a final-stage study missed its main goal.
Related posts
Blog articles that cover Zinc-L-carnosine or Larazotide, newest first.
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.